Home >> Life Sciences >> Medical Devices

Hyaluronic Acid (Single Injection, Three Injection, Five Injection) Market for Osteoarthritis, Adhesive Prevention, Drug Delivery, Dermal Fillers Applications - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2014 – 2020

Published: Feb-2016 | Format: PDF | Zion | Number of pages: 110 | Code: MRS - 47488


The report covers forecast and analysis for the hyaluronic acid market on a global and regional level. The study provides historic data of 2014 along with a forecast from 2015 to 2020 based revenue (USD Million). The study includes drivers and restraints for the hyaluronic acid market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the hyaluronic acid market on a global level.

In order to give the users of this report a comprehensive view on the hyaluronic acid market we have included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the hyaluronic acid market has also been included. The study encompasses a market attractiveness analysis, wherein product segments and application segments are benchmarked based on their market size, growth rate and general attractiveness.

The study provides a decisive view on the hyaluronic acid market by segmenting the market based on products, applications and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2014 to 2020. Based on products the market is segmented into single injection, three injections, and five injections. Key application market covered under this study includes osteoarthritis, adhesive prevention, drug delivery, dermal fillers. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East & Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil. This segmentation includes demand for hyaluronic acid based on individual applications in all the regions and countries.

The report also includes detailed profiles of end players such as Alcon, Inc., Allergan, Inc., Anika Therapeutics, Inc., F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Inc., Fidia Farmaceutici SpA, GALDERMA S.A., Hyaltech Ltd., LifeCore Biomedical LLC, Meiji Seika Pharma Co., Ltd., Merz Aesthetics, Inc., Sanofi, Salix Pharmaceuticals, Inc., Seikagaku Corporation, Shanghai Jingfeng Pharmaceutical Co., Ltd., Smith & Nephew plc, TRB CHEMEDICA INTERNATIONAL SA, Zimmer Holdings, Inc. The detailed description of players includes parameters such as company overview, financial overview, business strategies and recent developments of the company.
 
This report segments the global hyaluronic acid market as follows:

Global Hyaluronic Acid Market: Product Segment Analysis

  • Single-injection
  • Three-injection
  • Five-injection

 Global Hyaluronic Acid Market: Application Segment Analysis

  • Osteoarthritis
  • Adhesive Prevention
  • Drug Delivery
  • Dermal Fillers

Global Hyaluronic Acid Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East & Africa

Chapter 1. Introduction

  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology

Chapter 2. Executive Summary

  • 2.1. Global hyaluronic acid market, 2014 - 2020 (USD Million)
  • 2.2. Global hyaluronic acid market : Snapshot

Chapter 3. Hyaluronic acid – Market Dynamics

  • 3.1. Introduction
  • 3.2. Market drivers
    • 3.2.1. Global hyaluronic acid market drivers: Impact analysis
    • 3.2.2. Growing medical and cosmetic applications
    • 3.2.3. Physical properties of hyaluronic acid products
  • 3.3. Market restraints
    • 3.3.1. Global hyaluronic acid market restraints: Impact analysis
    • 3.3.2. Allergic reactions
    • 3.3.3. Cost effective treatments along with several regulations concerns
  • 3.4. Opportunities
    • 3.4.1. Research and development
    • 3.4.2. Beauty products with hyaluronic acid
  • 3.5. Porter’s five forces analysis
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. Threat from new entrants
    • 3.5.4. Threat from new substitutes
    • 3.5.5. Degree of competition
  • 3.6. Market attractiveness analysis
    • 3.6.1. Market attractiveness analysis, by products segment
    • 3.6.2. Market attractiveness analysis, by application segment
    • 3.6.3. Market attractiveness analysis, by regional segment

Chapter 4. Global Hyaluronic acid Market – Competitive Landscape

  • 4.1. Company market share, 2014
  • 4.2. Price trend analysis

Chapter 5. Global Hyaluronic acid Market – Product Segment Analysis

  • 5.1. Global hyaluronic acid market: Product overview
    • 5.1.1. Global hyaluronic acid market revenue share, by product, 2014 and 2020
  • 5.2. Single Injection
    • 5.2.1. Global single injection market , 2014 – 2020 (USD Million)
  • 5.3. Three Injection
    • 5.3.1. Global three injection market , 2014 – 2020 (USD Million)
  • 5.4. Five Injection
    • 5.4.1. Global five injection market , 2014 – 2020 (USD Million)

Chapter 6. Global Hyaluronic acid Market – Application Segment Analysis

  • 6.1. Global hyaluronic acid market: Application overview
    • 6.1.1. Global hyaluronic acid market revenue share, by application, 2014 and 2020
  • 6.2. Osteoarthritis
    • 6.2.1. Global hyaluronic acid market for osteoarthritis, 2014 - 2020(USD Million)
  • 6.3. Adhesive Prevention
    • 6.3.1. Global hyaluronic acid market for adhesive prevention, 2014 - 2020(USD Million)
  • 6.4. Drug Delivery
    • 6.4.1. Global hyaluronic acid market for drug delivery, 2014 - 2020(USD Million)
  • 6.5. Dermal Fillers
    • 6.5.1. Global hyaluronic acid market for dermal filters, 2014 - 2020(USD Million)

Chapter 7. Global Hyaluronic acid Market – Regional Segment Analysis

  • 7.1. Global hyaluronic acid market: Regional overview
    • 7.1.1. Global hyaluronic acid market revenue share, by region, 2014 and 2020
  • 7.2. North America
    • 7.2.1. North America hyaluronic acid market revenue, by product, 2014 – 2020 (USD Million)
    • 7.2.2. North America hyaluronic acid market revenue, by application, 2014 – 2020 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. U.S. hyaluronic acid market revenue, by product, 2014 – 2020 (USD Million)
      • 7.2.3.2. U.S. hyaluronic acid market revenue, by application, 2014 – 2020 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe hyaluronic acid market revenue, by product, 2014 – 2020 (USD Million)
    • 7.3.2. Europe hyaluronic acid market revenue, by application, 2014 – 2020 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany hyaluronic acid market revenue, by product, 2014 – 2020, (USD Million)
      • 7.3.3.2. Germany hyaluronic acid market revenue, by application, 2014 – 2020, (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France hyaluronic acid market revenue, by product, 2014 – 2020, (USD Million)
      • 7.3.4.2. France hyaluronic acid market revenue, by application, 2014 – 2020, (USD Million)
    • 7.3.5. UK
      • 7.3.5.1. UK hyaluronic acid market revenue, by product, 2014 – 2020 (USD Million)
      • 7.3.5.2. UK hyaluronic acid market revenue, by application, 2014 – 2020 (USD
        Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific hyaluronic acid market revenue, by product, 2014 – 2020, (USD Million)
    • 7.4.2. Asia Pacific hyaluronic acid market revenue, by application, 2014 – 2020, (USD Million)
    • 7.4.3. China
      • 7.4.3.1. China hyaluronic acid market revenue, by product, 2014 – 2020 (USD Million)
      • 7.4.3.2. China hyaluronic acid market revenue, by application, 2014 – 2020 (USD Million)
    • 7.4.4. Japan
      • 7.4.4.1. Japan hyaluronic acid market revenue, by product, 2014 – 2020 (USD Million)
      • 7.4.4.2. Japan hyaluronic acid market revenue, by application, 2014 – 2020 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. India hyaluronic acid market revenue, by product, 2014 – 2020 (USD Million)
      • 7.4.5.2. India hyaluronic acid market revenue, by application, 2014 – 2020 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America hyaluronic acid market revenue, by product, 2014 – 2020 (USD Million)
    • 7.5.2. Latin America hyaluronic acid market revenue, by application, 2014 – 2020 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Brazil hyaluronic acid market revenue, by product, 2014 – 2020 (USD Million)
      • 7.5.3.2. Brazil hyaluronic acid market revenue, by application, 2014 – 2020 (USD Million)
  • 7.6. Middle East & Africa
    • 7.6.1. Middle East & Africa hyaluronic acid market revenue, by product, 2014 – 2020 (USD Million)
    • 7.6.2. Middle East & Africa hyaluronic acid market revenue, by application, 2014 – 2020 (USD Million)

Chapter 8. Company Profile

  • 8.1. Alcon, Inc.
    • 8.1.1. Overview
    • 8.1.2. Financials
    • 8.1.3. Product portfolio
    • 8.1.4. Business strategy
    • 8.1.5. Recent developments
  • 8.2. Allergan, Inc.
    • 8.2.1. Overview
    • 8.2.2. Financials
    • 8.2.3. Product portfolio
    • 8.2.4. Business strategy
    • 8.2.5. Recent developments
  • 8.3. Anika Therapeutics, Inc.
    • 8.3.1. Overview
    • 8.3.2. Financials
    • 8.3.3. Product portfolio
    • 8.3.4. Business strategy
    • 8.3.5. Recent developments
  • 8.4. F. Hoffmann-La Roche Ltd.
    • 8.4.1. Overview
    • 8.4.2. Financials
    • 8.4.3. Product portfolio
    • 8.4.4. Business strategy
    • 8.4.5. Recent developments
  • 8.5. Ferring Pharmaceuticals, Inc.
    • 8.5.1. Overview
    • 8.5.2. Financials
    • 8.5.3. Product portfolio
    • 8.5.4. Business strategy
    • 8.5.5. Recent developments
  • 8.6. Fidia Farmaceutici SpA
    • 8.6.1. Overview
    • 8.6.2. Financials
    • 8.6.3. Product portfolio
    • 8.6.4. Business strategy
    • 8.6.5. Recent developments
  • 8.7. GALDERMA S.A.
    • 8.7.1. Overview
    • 8.7.2. Financials
    • 8.7.3. Product portfolio
    • 8.7.4. Business strategy
    • 8.7.5. Recent developments
  • 8.8. Hyaltech Ltd.
    • 8.8.1. Overview
    • 8.8.2. Financials
    • 8.8.3. Product portfolio
    • 8.8.4. Business strategy
    • 8.8.5. Recent developments
  • 8.9. LifeCore Biomedical LLC
    • 8.9.1. Overview
    • 8.9.2. Financials
    • 8.9.3. Product portfolio
    • 8.9.4. Business strategy
    • 8.9.5. Recent developments
  • 8.10. Meiji Seika Pharma Co.
    • 8.10.1. Overview
    • 8.10.2. Financials
    • 8.10.3. Product portfolio
    • 8.10.4. Business strategy
    • 8.10.5. Recent developments
  • 8.11. Ltd., Merz Aesthetics, Inc.
    • 8.11.1. Overview
    • 8.11.2. Financials
    • 8.11.3. Product portfolio
    • 8.11.4. Business strategy
    • 8.11.5. Recent developments
  • 8.12. Sanofi
    • 8.12.1. Overview
    • 8.12.2. Financials
    • 8.12.3. Product portfolio
    • 8.12.4. Business strategy
    • 8.12.5. Recent developments
  • 8.13. Salix Pharmaceuticals, Inc.
    • 8.13.1. Overview
    • 8.13.2. Financials
    • 8.13.3. Product portfolio
    • 8.13.4. Business strategy
    • 8.13.5. Recent developments
  • 8.14. Seikagaku Corporation
    • 8.14.1. Overview
    • 8.14.2. Financials
    • 8.14.3. Product portfolio
    • 8.14.4. Business strategy
    • 8.14.5. Recent developments
  • 8.15. Shanghai Jingfeng Pharmaceutical Co. Ltd.
    • 8.15.1. Overview
    • 8.15.2. Financials
    • 8.15.3. Product portfolio
    • 8.15.4. Business strategy
    • 8.15.5. Recent developments
  • 8.16. Smith & Nephew plc
    • 8.16.1. Overview
    • 8.16.2. Financials
    • 8.16.3. Product portfolio
    • 8.16.4. Business strategy
    • 8.16.5. Recent developments
  • 8.17. TRB CHEMEDICA INTERNATIONAL SA
    • 8.17.1. Overview
    • 8.17.2. Financials
    • 8.17.3. Product portfolio
    • 8.17.4. Business strategy
    • 8.17.5. Recent developments
  • 8.18. Zimmer Holdings, Inc.
    • 8.18.1. Overview
    • 8.18.2. Financials
    • 8.18.3. Product portfolio
    • 8.18.4. Business strategy
    • 8.18.5. Recent developments

List of Tables

1. Hyaluronic acid  market: Market snapshot
2. Drivers of global hyaluronic acid  market: Impact analysis
3. Restraints of global hyaluronic acid  market: Impact analysis  
4. North America hyaluronic acid  market revenue, by product, 2014 - 2020 (USD Million)
5. North America hyaluronic acid  market revenue, by application, 2014 - 2020 (USD Million)
6. U.S. hyaluronic acid  market revenue, by product, 2014 - 2020 (USD Million)
7. U.S. hyaluronic acid  market revenue, by application, 2014 - 2020 (USD Million)
8. Germany hyaluronic acid  market revenue, by product, 2014 - 2020 (USD Million)
9. Germany hyaluronic acid  market revenue, by application, 2014 - 2020 (USD Million)
10. France hyaluronic acid  market revenue, by product, 2014 - 2020 (USD Million)
11. France hyaluronic acid  market revenue, by application, 2014 - 2020 (USD Million)
12. UK hyaluronic acid  market revenue, by product, 2014 - 2020 (USD Million)
13. UK hyaluronic acid  market revenue, by application, 2014 - 2020 (USD Million)
14. Asia Pacific hyaluronic acid  market revenue, by product, 2014 - 2020 (USD Million)
15. Asia Pacific hyaluronic acid  market revenue, by application, 2014 - 2020 (USD Million)
16. China hyaluronic acid  market revenue, by product 2014 - 2020 (USD Million)
17. China hyaluronic acid  market revenue, by application 2014 - 2020 (USD Million)
18. Japan hyaluronic acid  market revenue, by product, 2014 - 2020 (USD Million)
19. Japan hyaluronic acid  market revenue, by application, 2014 - 2020 (USD Million)
20. India hyaluronic acid  market revenue, by product, 2014 - 2020 (USD Million)
21. India hyaluronic acid  market revenue, by application, 2014 - 2020 (USD Million)
22. Latin America hyaluronic acid  market revenue, by product, 2014 - 2020 (USD Million)
23. Latin America hyaluronic acid  market revenue, by application, 2014 - 2020 (USD Million)
24. Brazil hyaluronic acid  market revenue, by product, 2014 - 2020 (USD Million)
25. Brazil hyaluronic acid  market revenue, by application, 2014 - 2020 (USD Million)
26. Middle East and Africa hyaluronic acid  market revenue, by product, 2014 - 2020 (USD Million)
27. Middle East and Africa hyaluronic acid  market revenue, by application, 2014 - 2020 (USD Million)


List of Figures

1. Market research process
2. Market research methodology
3. Global hyaluronic acid market revenue, 2014 - 2020 (USD Million)
4. Porter’s five forces analysis
5. Hyaluronic acid : Market attractiveness analysis, by product segment
6. Hyaluronic acid products: Market attractiveness analysis, by application segment
7. Hyaluronic acid products: Market attractiveness analysis, by regional segment
8. Company market share analysis, 2014 and 2020
9. Global hyaluronic acid  market revenue share by application, 2014 and 2020
10. Global  hyaluronic acid  market for osteoarthritis, 2014 – 2020, (USD Million)
11. Global  hyaluronic acid  market for adhesive prevention, 2014 – 2020, (USD Million)
12. Global hyaluronic acid  market for  drug delivery , 2014 – 2020, (USD Million)
13. Global hyaluronic acid  market for dermal fillers, 2014 – 2020, (USD Million)

Inquiry For Buying



Request Sample




Zion Research uses the synergy of combination of both primary research and secondary research for its research reports. For this study, we have conducted extensive primary research, wherein we have conducted in-depth interviews of the key opinion leader of this industry. Primary research make up for the biggest chunk of our data sources in addition to secondary research.

We referred to product literature of leading industry participants, annual reports, press releases, government publications, and other relevant sources for data collection and analysis thereof. Secondary research also includes a search of recent trade journals, technical writing, internet sources, and statistical data from government websites, trade associations and agencies.  

Zion Research has collected key data related to the Hyaluronic Acid Market and analyzed these data using a variety of methods. The market dynamics have been ascertained following a detailed study of the micro, meso, and macroeconomic indicators of the market.

This report is based on in-depth qualitative and quantitative analyses of the Global Hyaluronic Acid Market. The quantitative analysis involved the application of various projection and sampling techniques. The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions.

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically partake in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Based on the research results and technical insights thus gathered, Zion research analysts have provided a comprehensive analysis of the varied aspects of the market. The impact of global economic conditions and other macroeconomic indicators was also considered when assessing the market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Hyaluronan or HA is another name of hyaluronic acid. It is an organic compound which belongs to the division of carbohydrates and additional segment of polysaccharides. It  is an anionic, nonsulfated glycosaminoglycan dispersed extensively throughout connective, epithelial, and neural tissues. HA is manufactured in laboratory by various processes which consist of extraction from rooster combs, in-vitro and bacterial production. It is a nonsulfated glycosaminoglycan which is available in the connective, neural and epithelial tissues of living organisms. Hyaluronic acid performs vital role in multiple functions in the human body such as retaining water in body tissues and transporting nutrients through the body because it naturally present in human body.

The major driving factor for the global hyaluronic acid market is rapidly growing demand from medical and cosmetic applications such as skin care products, osteoarthritis, adhesive prevention, drug delivery, dermal fillers etc. Another key driving factor is increasing health awareness among the people. This has been resulted into increasing demand for healthcare products as per the patient’s convenience in various treatments. Use of hyaluronic acid in treatments like mouth sore, aging skin, dry eye, etc. has provided strong boost to hyaluronic acid market. Increasing technology advancement to provide better health services expected to fuel the hyaluronic acid market over the forecast period. Additionally, increasing trend towards plastic surgeries is boosting the growth of the market. However, hyaluronic acid may cause an allergic reaction which is expected to hamper the growth of hyaluronic acid market.

Hyaluronic acid MarketOn the basis of applications, hyaluronic acid market has been classified into osteoarthritis, adhesive prevention, drug delivery, dermal fillers. Osteoarthritis was the largest application segment of the market due to the presence of large suitable needs and the physical properties of hyaluronic acid which increased patient comfort. Vesicoureteral reflux also one of the important application segments in the global hyaluronic acid market.

Hyaluronic acid market is segmented on the basis of different product such as single injection, three injection, and five injection. The five injection segment dominated the market with largest share of the total market in 2014. Single-injection and three-injection also accounted for significant share owing to the growing preference for short-duration treatments among patients. Single-injection and three-injection are expected to be growing at a rapid pace in the years to come.

North America was the leading regional market for hyaluronic acid in 2014. North America is followed by Europe. The Asia Pacific also expected to dominate the global hyaluronic acid market over forecast period. However, with increasing patient awareness levels coupled with aesthetic and anti aging procedures and growing occurrence of target diseases, Asia Pacific is expected to witness lucrative growth during 2015 to 2020. Europe, Latin America and Middle East & Africa are also expected to experience significant growth of hyaluronic acid market in the years to come.

Some of the major industry participants in hyaluronic acid market includes Alcon, Inc., Allergan, Inc., Anika Therapeutics, Inc., F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Inc., Fidia Farmaceutici SpA, GALDERMA S.A., Hyaltech Ltd., LifeCore Biomedical LLC, Meiji Seika Pharma Co., Ltd., Merz Aesthetics, Inc., Sanofi, Salix Pharmaceuticals, Inc., Seikagaku Corporation, Shanghai Jingfeng Pharmaceutical Co., Ltd., Smith & Nephew plc, TRB CHEMEDICA INTERNATIONAL SA, Zimmer Holdings, Inc.


Related Reports

Nephrology and Urology Devices - Global Market Outlook (2015-2022)

Jun-2016 | Stratistics MRC | Pages : 173 | Code : MRS-68165 | 4150

According to Stratistics MRC, the Global Nephrology and Urology Devices is valued at $17.28 billion in 2015 and is expected to grow at a CAGR of 7.2% to reach $28.27 billion by 2022. Rising occurrence of chronic kidney diseases, increased spending on healthcare among the emerging regions and growing aged population across the world are some of the factors favoring the market growth. Moreover, the growing awareness about the benefits of these devices such as abridged recovery and treatment t Read more

Medical Alert Systems - Global Market Outlook (2015-2022)

Jun-2016 | Stratistics MRC | Pages : 121 | Code : MRS-68148 | 4150

According to Stratistics MRC, the Global Medical Alert Systems market is estimated at $5.48 billion in 2015 and is expected to grow at a CAGR of 7.8% to reach $9.27 billion by 2022. In time of emergency to provide assistance by healthcare individuals the medical systems are used. Increasing number of ageing population and healthcare awareness coupled with independent lifestyle for soothing life are the factors fueling the market growth. These devices being easily accessible and affordable Read more

Medical Disposables - Global Market Outlook (2015-2022)

Jun-2016 | Stratistics MRC | Pages : 130 | Code : MRS-68144 | 4150

According to Stratistics MRC, the Global Medical Disposables Market is accounted for $178.37 billion in 2015 and is expected to reach $267.96 billion by 2022 growing at a CAGR of 5.9%. In the present scenario healthcare advancement in techniques and new care products are hovering over the market. Rising geriatric population and more occurrence of chronic disease which need utmost care in hospitals are the reasons behind the growth of the market. Moreover stringent FDA and GMP approval norms Read more

Bone Graft and Substitutes - Global Market Outlook (2015-2022)

Jun-2016 | Stratistics MRC | Pages : 138 | Code : MRS-68137 | 4150

According to Stratistics MRC, the Global Bone Graft and Substitutes market is accounted for $3.02 billion in 2015 and is expected to reach $4.33 billion by 2022 growing at a CAGR of 5.3%. Bones in general have healing capacity but as a defect moves in ahead of it, surges and substitutes play a predominant role in the market. Increasing demand from customers, due to aged population and more fracture cases, the market is being fuelled up by many favorable factors. But still the limited suppl Read more

Bariatric Surgery Devices - Global Market Outlook (2015-2022)

Jun-2016 | Stratistics MRC | Pages : 131 | Code : MRS-68136 | 4150

According to Stratistics MRC, the Global Bariatric Surgery Devices Market is accounted for $1.35 billion in 2015 and is expected to reach $2.96 billion by 2022 growing at a CAGR of 11.9%. Huge technological advancements in obesity healthcare is creating a buzz among obesity struck people, who are opting for Bariatric Surgery Devices as treatment. However increasing demand for such procedures had created opportunities for introducing specialized devices in market which are favoring the marke Read more

Auto Injectors - Global Market Outlook (2015-2022)

Jun-2016 | Stratistics MRC | Pages : 134 | Code : MRS-68135 | 4150

According to Stratistics MRC, the Global Auto Injectors Market is accounted for $1.10 billion in 2015 and is expected to reach $3.78 billion by 2022 growing at a CAGR of 19.42%. As large number of patients are opting for self administered treatment and care there is a flawless increase in use of Auto Injectors. Moreover, the high prevailing patients of anaphylaxis had presented a huge demand for the market which seems as pertaining factor behind the market growth. At the same time high cost Read more

Medical Radiation Detection - Global Market Outlook (2015-2022)

Jun-2016 | Stratistics MRC | Pages : 124 | Code : MRS-68132 | 4150

According to Stratistics MRC, the Medical Radiation Detection Market accounted for $0.87 billion in 2015 and is expected to reach $1.58 billion by 2022 growing at a CAGR of 8.8% from 2015 to 2022. Increasing incidences of cancer and rising healthcare industry worldwide are some of the factors driving the market growth. However, absence of skilled professionals in the field is inhibiting the market. Rising count of diagnostic imaging centers is providing ample of growth opportunities for the Read more

Prefilled Syringes - Global Market Outlook (2015-2022)

Jun-2016 | Stratistics MRC | Pages : 178 | Code : MRS-68117 | 4150

According to Stratistics MRC, the Global Prefilled Syringes market is accounted for $4.45 billion in 2015 and is expected to reach $11.18 billion by 2022 growing at a CAGR of 14.0% during the forecast period. Rising prevalence of chronic diseases, technological advancements and rising number of biologics are the key factors fueling the market growth. On the other hand, stringent government regulations and high cost of these syringes are hampering the market. Rising combination therapy is Read more

MEMS Medical Devices - Global Market Outlook (2015-2022)

Jun-2016 | Stratistics MRC | Pages : 175 | Code : MRS-68115 | 4150

According to Stratistics MRC, the Global Micro-Electro-Mechanical Systems (MEMS) Medical Devices market is accounted for $3.12 billion in 2015 and is expected to reach $10.41 billion by 2022 growing at a CAGR of 18.7% during the forecast period. Growing occurrence of infectious and chronic diseases, technology advancements and growing aging population are the key factors fueling the market growth. On the other hand, less awareness, rising competition and strict government regulations are hi Read more

Hip & Knee Reconstruction Devices - Global Market Outlook (2015-2022)

Jun-2016 | Stratistics MRC | Pages : 157 | Code : MRS-68113 | 4150

According to Stratistics MRC, the Hip and Knee Reconstruction market accounted for $18.3 billion in 2015 and is expected to grow at a CAGR of 11.19% to reach $38.46 billion by 2022. The factors such as increase in the occurrence of osteoporosis in aging population, increasing number of obesity cases and raising multiple advancements in hip and knee reconstructive products, are some of the factors driving the market. However, multiple numbers of alternative treatments and high cost of equipm Read more

Single User | $(USD)4199 View Pricing